Red White & Bloom Appoints CFO With Extensive Beverage Alcohol Experience

Red White & Bloom (CSE: RWB) this morning appointed a new chief financial officer to the firms executive team, replacing Theo van der Linde, whom will remain as a director. Taking on the role will be that of Christopher Ecken, whom has been an executive within the alcohol industry for decades.

Ecken comes highlight experienced within the beverage alcohol space, having spent two and a half decades at Brown-Forman. Brown-Forman produce some of the largest alcohol brands globally, including Jack Daniel’s and Woodford Reserve. Most recently he held the title of Senior Vice President, Director Global Analytics, after having served in numerous VP rolls with the company.

Ecken is said to be experienced in a number of financial roles, including strategy and forecasting, execution, risk management and controls, operational management, and M&A due diligence. Previously, he has history of working with KPMG, while holding an MBA from Southern Methodist University Graduate School of Business.

The appointment is said to benefit the company, “on its trajectory for uplisting, subject to “safe banking” for the cannabis industry.”

“Chris’ extensive experience as a financial executive at a major NYSE-listed player in the alcohol beverage industry – a highly regulated industry similar to cannabis — will be a tremendous asset. His rise through the ranks and track record of accomplishments at each level is testament to his financial acumen, visionary leadership and strategic mindset. We anticipate his specialized skills will help shape sustainable long-term growth, the shift to cannabis industry safe banking, and an upward trajectory toward a listed exchange for Red White & Bloom,” commented CEO Brad Rogers.

Red White & Bloom last traded at $0.74 on the CSE.

FULL DISCLOSURE: Red White & Bloom is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Red White & Bloom on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply